Synjardy is a prescription medication combining empagliflozin (5mg) and metformin hydrochloride (1000mg) in film-coated tablet form. Manufactured by Boehringer Ingelheim, this combination therapy is used to treat type 2 diabetes mellitus in adults, containing 60 tablets per package. This medication combines two active ingredients - empagliflozin, which is a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and metformin, which belongs to the biguanide class of diabetes medications. The tablets are intended for oral use and should be taken as prescribed by a healthcare provider. This is a prescription-only medication that requires proper medical supervision and regular monitoring.